The Institute of Cardiovascular & Medical Sciences main hub is the purpose-built BHF Glasgow Cardiovascular Research Centre facility at the University of Glasgow. The Director of Institute is Prof Rhian Touyz, MBBCh, MSc, PhD.

During the past decade, Glasgow Cardiovascular Research Centre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Glasgow Cardiovascular Research Centre" #1 collaborator was "University of Glasgow" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Glasgow Cardiovascular Research Centre" are "Diabetes Mellitus, Type 2" (1 trials), "Heart Failure" (1 trials) and "Weight Management" (1 trials). Many other conditions were trialed in "Glasgow Cardiovascular Research Centre" in a lesser frequency.

Most popular intervention types in "Glasgow Cardiovascular Research Centre" are "Behavioral" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Small Talk Big Difference Immediate access training" (1 trials), "Small Talk Big Difference delayed access training" (1 trials), "Valsartan" (1 trials) and "sacubitril/valsartan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Glasgow Cardiovascular Research Centre" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Glasgow Cardiovascular Research Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Glasgow Cardiovascular Research Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Glasgow Cardiovascular Research Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".